7 October 2024
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Appointment of Non-Executive Director
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that, further to the announcement of 4 September 2024, Frederik Bruhn-Petersen has been appointed as a Non-executive Director of the Company.
Frederik is currently working in a managing role for Holdingselskabet af 29. Juni 2010 Aps, an investment vehicle of the Bruhn-Petersen family, which is interested in 33,160,000 ordinary shares in the Company, representing 20.97% of the Company's current issued share capital.
Frederik is an entrepreneur and is the co-founder of RobinHus A/S, a disruptive real estate brokerage in Denmark, driving the business from its start-up phase to a national franchise based operator, before ultimately selling to Denmark's largest real estate player, EDC A/S. Frederik has a Masters of Law Degree from Copenhagen University.
Frederik is interested in 3,000,000 ordinary shares in the Company.
For further information, please contact:
ProBiotix Health plc |
|||
Steen Andersen, Chief Executive Officer |
Contact via Walbrook below |
||
|
|
||
Peterhouse Capital Limited (Aquis Corporate Adviser and Broker) |
Tel: 020 7220 9793 |
||
Mark Anwyl |
|
||
|
|
||
Walbrook PR Ltd |
probiotix@walbrookpr.com or 07876 741 001 |
||
Anna Dunphy |
|
||
Save as set out below, there is no further information regarding Frederik Bruhn-Petersen that is required to be disclosed pursuant to Rule 4.9 of the Aquis Growth Market Access Rulebook.
CURRENT DIRECTORSHIPS
VICS 6998 ApS
HCS 82 ApS
K/S BAXTERGATE (DONCASTER)